Aspirin use after HeartMate 3 implantation fell from 90.2% to 52.7% after new trial evidence, with no higher adjusted risk of death or major complications.
Need help?
Contact usAspirin use after HeartMate 3 implantation fell from 90.2% to 52.7% after new trial evidence, with no higher adjusted risk of death or major complications.